Head of Glaxo is in for a bumper deal in the coming period as it looks at potential revenue of £3bn for the supply of swine flu drugs. The Chief has been quoted as saying "We don't know how big this deal is going to be, but no-one can say we aren't ready".
Greedy pharmaceutical company.
Greedy pharmas (editor)
0 comments:
Post a Comment